RICHARD RALLS: Open Payments
NPI 1427412212 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 24 payments from 10 companies in 2025. Trend: 2023 $28 · 2024 $156 · 2025 $632
Food & beverage: $533Education: $99
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $107 |
| SEAGEN INC. | 1 | $99 |
| ARRAY BIOPHARMA INC | 6 | $98 |
| Daiichi Sankyo Inc. | 3 | $88 |
| AstraZeneca Pharmaceuticals LP | 2 | $61 |
| Merck Sharp & Dohme LLC | 2 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Eisai Inc. | 2 | $41 |
| Gilead Sciences, Inc. | 1 | $24 |
| BeOne Medicines USA, Inc. | 1 | $17 |
Products named: OPDIVO, BRAFTOVI, ENHERTU, KEYTRUDA, Lenvima, DATROWAY, Trodelvy, FRUZAQLA.
Industry payments across FL — which companies pay providers there.
